Meng Q, Sun H* and LiuJ*. Precise somatic genomeediting for treatment of inborn errors of immunity. FrontImmunol, Accepted. Zhang G†, Liu Y†, Huang S†, QuS, Cheng D, Yao Y, Ji Q, Wang X*, Huang X* and LiuJ*. Enhancement of primeediting via xrRNA motif-joined pegRNA.Nat Commun2022, 13(1):1856. Wang Y†, Zhang G†, Meng Q†,Huang S, Guo P, Leng Q, Liu G*, Huang X* and LiuJ*. Precise tumor immunerewiring via synthetic CRISPRa circuits gated by concurrentgain/loss of transcription factors.Nat Commun2022, 13(1):1454. Meng Q†, Yang H†, Zhang G, Ma P,Liu X, Dang L, Li G, Huang X, Wang X*, LiuJ* and Leng Q*.CRISPR/Cas12a-assisted rapid identification of beer spoilagebacteria. Innov Food SciEmerg Technol 2021,74：102854. Gup P†, Yang L†, Zhang M, Zhang Y,Tong Y, Cao Y and Liu J*.A monocyte-orchestrated IFN-I-to-IL-4 cytokine axis instigatespro-tumoral macrophages and thwarts poly(I:C) therapy. JImmunol 2021, 207:408-420. Tong Y†, Zhou L†, Yang L, Cao Y,Qin FX and Liu J*.Concomitant Type I IFN and M-CSF signaling reprograms monocytedifferentiation to drive pro-tumoral arginase production.EBioMedicine2019, 39:132-44.
|
